I received a partial shipment yesterday.
The pills have always worked very well...as expected.
That's why I ordered from you again this year...just like last year.
In fact, yours work better than the 50 mg brand name pills I still have!!
An since your pills are scored (unlike the brand name ones that I have to use a knife
to split),
I can easily lower the dosage to 25 mg...which is all I need.
Thank you for a great product at a reasonable price!
Takeda introduces Edarbyclor drug in US - Pharmaceutical Business Review
Takeda introduces Edarbyclor drug in USPharmaceutical Business ReviewIn a phase 3 clinical trial, Edarbyclor (40/25 mg) was found to reduce systolic blood pressure compared to the fixed-dose combination of olmesartan medoxomil-hydrochlorothiazide at its maximum dose (40/25 mg).
Forest Laboratories, Inc. Reports Fiscal Year Third Quarter 2012 Earnings Per ... - MarketWatch (press release)
Forest Laboratories, Inc.
Daiichi Sankyo net profit dips by 78% in first nine months - pharmabiz.com
Daiichi Sankyo net profit dips by 78% in first nine monthspharmabiz.
Congress MP terms proposed pharma policy incomplete and disappointing - pharmabiz.com
Congress MP terms proposed pharma policy incomplete and disappointingpharmabiz.
Takeda gains approval for hypertension drug Azilva in Japan - PMLiVE
Takeda gains approval for hypertension drug Azilva in JapanPMLiVEPrior studies had also shown it to be superior to valsartan, developed and sold by Novartis as Diovan, and Daiichi Sankyo's Benicar/Olmetec (olmesartan).